Heart Test Laboratories Inc. Common Stock (NASDAQ:HSCS) — Market Cap & Net Worth
Market Cap & Net Worth: Heart Test Laboratories Inc. Common Stock (HSCS)
Heart Test Laboratories Inc. Common Stock (NASDAQ:HSCS) has a market capitalization of $13.70 Million ($13.70 Million) as of October 10, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #26242 globally and #5476 in its home market, demonstrating a -27.27% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Heart Test Laboratories Inc. Common Stock's stock price $3.04 by its total outstanding shares 4505999 (4.51 Million).
Heart Test Laboratories Inc. Common Stock Market Cap History: 2022 to 2026
Heart Test Laboratories Inc. Common Stock's market capitalization history from 2022 to 2026. Data shows change from $378.46 Million to $13.70 Million (-60.62% CAGR). Check latest Heart Test Laboratories Inc. Common Stoc stock price today for real-time trading data and today's change.
Index Memberships
Heart Test Laboratories Inc. Common Stock is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.59 Trillion | 0.00% | #735 of 976 |
|
NASDAQ Composite
IXIC
|
$42.16 Trillion | 0.00% | #2414 of 3165 |
Weight: Heart Test Laboratories Inc. Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Heart Test Laboratories Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Heart Test Laboratories Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Heart Test Laboratories Inc. Common Stoc cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
3171.62x
Heart Test Laboratories Inc. Common Stock's market cap is 3171.62 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $378.46 Million | $14.37K | -$4.83 Million | 26331.20x | N/A |
| 2023 | $77.05 Million | $5.15K | -$6.35 Million | 14961.67x | N/A |
| 2024 | $17.21 Million | $18.60K | -$6.61 Million | 925.43x | N/A |
| 2025 | $13.92 Million | $4.35K | -$8.77 Million | 3200.81x | N/A |
| 2026 | $13.70 Million | $4.32K | -$9.14 Million | 3171.62x | N/A |
Competitor Companies of HSCS by Market Capitalization
Companies near Heart Test Laboratories Inc. Common Stock in the global market cap rankings as of October 10, 2026. See HSCS net asset quality index to understand what proportion of total assets are financed by equity.
Key companies related to Heart Test Laboratories Inc. Common Stock by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #133 globally with a market cap of $171.26 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #233 globally with a market cap of $106.24 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #133 | Abbott Laboratories | NYSE:ABT | $171.26 Billion | $98.49 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $87.75 |
| #233 | Stryker Corporation | NYSE:SYK | $106.24 Billion | $276.97 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Heart Test Laboratories Inc. Common Stock Historical Marketcap From 2022 to 2026
Between 2022 and today, Heart Test Laboratories Inc. Common Stock's market cap moved from $378.46 Million to $ 13.70 Million, with a yearly change of -60.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $13.70 Million | -1.62% |
| 2025 | $13.92 Million | -19.11% |
| 2024 | $17.21 Million | -77.66% |
| 2023 | $77.05 Million | -79.64% |
| 2022 | $378.46 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 9th, 2026 the market cap of Heart Test Laboratories Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.70 Million USD |
| MoneyControl | $13.70 Million USD |
| MarketWatch | $13.70 Million USD |
| marketcap.company | $13.70 Million USD |
| Reuters | $13.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Heart Test Laboratories Inc. Common Stock
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related… Read more